Pharmaceutical "Biopharma" company will invest $30 mln in the building of the new blood preparation fractionator factory.
This information became out in the open after the company`s press release, which was made on the foundation stone ceremony of the second phase of a project.
As a result of building of the second phase of project plasma processing capacity will be increased by three times from 90 t up to 270 t.
Alongside with the foundation stone ceremony "Biopharma" also opened the first phase of the new scientific and production complex, in which the company invested more than $40 mln.
The complex building project is funded by both Ukrainian and foreign investors, namely American Horizon Capital company and Dutch FMO development bank.
